Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis
Zeyu Han , Ketao Wang , Shenglong Ding , Mingzhu Zhang
Bone Research ›› 2024, Vol. 12 ›› Issue (1) : 69
Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis
Osteoarthritis (OA) poses a significant challenge in orthopedics. Inflammatory pathways are regarded as central mechanisms in the onset and progression of OA. Growing evidence suggests that senescence acts as a mediator in inflammation-induced OA. Given the lack of effective treatments for OA, there is an urgent need for a clearer understanding of its pathogenesis. In this review, we systematically summarize the cross-talk between cellular senescence and inflammation in OA. We begin by focusing on the mechanisms and hallmarks of cellular senescence, summarizing evidence that supports the relationship between cellular senescence and inflammation. We then discuss the mechanisms of interaction between cellular senescence and inflammation, including senescence-associated secretory phenotypes (SASP) and the effects of pro- and anti-inflammatory interventions on cellular senescence. Additionally, we focus on various types of cellular senescence in OA, including senescence in cartilage, subchondral bone, synovium, infrapatellar fat pad, stem cells, and immune cells, elucidating their mechanisms and impacts on OA. Finally, we highlight the potential of therapies targeting senescent cells in OA as a strategy for promoting cartilage regeneration.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
Hy, C. et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 8, 18–30 (2009). |
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
Zhang, W., Ouyang, H., Dass, C. R. & Xu, Jr. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res. 4, 15040 (2016). |
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
Gardner, S. E., Humphry, M., Bennett, M. R., & Clarke, M. C. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α–dependent senescence-associated secretory phenotype. Arteriosclerosis Thrombosis Vasc. Biol. 35, 1963–1974 (2015). |
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
Ribeiro, A., et al. Uremic toxin indoxyl sulfate promotes macrophage-associated low-grade inflammation and epithelial cell senescence. Int. J. Mol. Sci. 24, 8031 (2023). |
| [53] |
Lavandoski, P., et al. Eotaxin-1/CCL11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. Front. Immunol. 14, 1243537, (2023). |
| [54] |
|
| [55] |
Ortiz-Montero, P., Londoño-Vallejo, A. & Vernot, J.-P. Senescence-associated IL-6 and IL-8 cytokines induce a self-and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Communi. Signal. 15, 17 (2017). |
| [56] |
Ortiz-Montero, P., Londoño-Vallejo, A., & Vernot, J.-P. Senescence-associated IL-6 and IL-8 cytokines induce a self-and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun. Signal. 15, 1–18 (2017). |
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
Schroer, A. B. et al. Platelet factors attenuate inflammation and rescue cognition in ageing. Nature 620, 1071–1079 (2023). |
| [74] |
Zhang, Z., et al. Increased hyaluronan by naked mole-rat HAS2 extends lifespan in mice. Nature 621, 196–205 (2023). |
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
Gudkov, A. V. & Komarova, E. A. p53 and the carcinogenicity of chronic inflammation. Cold Spring Harb. Perspect. Med. 6, a026161 (2016). |
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
Cheng, A. W. M., Stabler, T. V., Bolognesi, M. & Kraus, V. B. Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthr. Cartil. 19, 118–125 (2011). |
| [94] |
Ya Sklyarov, A., Panasyuk, N., & Fomenko, I. S. Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis. J. Physiol. Pharmacol. 62, 65 (2011). |
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
Tang, L., Sim, I., Moqbel, S., Wu, L. J. H. & Toxicology, E. Dapansutrile ameliorated chondrocyte inflammation and osteoarthritis through suppression of MAPK signaling pathway. Hum. Exp. Toxicol. 41, 09603271221145401 (2022). |
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
Delmonico M. J. et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am. J. Clin. Nutr. 90, 1579–1585 (2009). |
| [110] |
Coppé, J.-P., Desprez, P.-Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99–118 (2010). |
| [111] |
|
| [112] |
Zeng, Y., Wang, P.-H., Zhang, M., & Du, J.-R.. Aging-related renal injury and inflammation are associated with downregulation of Klotho and induction of RIG-I/NF-κB signaling pathway in senescence-accelerated mice. Aging Clin. Exp. Res. 28, 69–76 (2016). |
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
|
| [132] |
|
| [133] |
|
| [134] |
|
| [135] |
|
| [136] |
|
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
|
| [143] |
|
| [144] |
|
| [145] |
|
| [146] |
|
| [147] |
|
| [148] |
|
| [149] |
|
| [150] |
|
| [151] |
|
| [152] |
|
| [153] |
|
| [154] |
|
| [155] |
|
| [156] |
|
| [157] |
|
| [158] |
|
| [159] |
|
| [160] |
|
| [161] |
|
| [162] |
|
| [163] |
|
| [164] |
|
| [165] |
|
| [166] |
Ioan-Facsinay, A., Kloppenburg, M. An emerging player in knee osteoarthritis: the infrapatellar fat pad. Arthritis. Res. Ther. 15, 1–9 (2013). |
| [167] |
|
| [168] |
Xie, C. & Chen, Q. J. C. r. r. Adipokines: new therapeutic target for osteoarthritis? Curr. Rheumatol. Rep. 21, 71 (2019). |
| [169] |
|
| [170] |
|
| [171] |
|
| [172] |
|
| [173] |
|
| [174] |
|
| [175] |
|
| [176] |
|
| [177] |
|
| [178] |
|
| [179] |
Bondeson, J. et al. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis (INTECH Open Access Publisher, 2012). |
| [180] |
Bondeson, J. et al. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis. Res. Ther. 8, 1–12 (2006). |
| [181] |
|
| [182] |
|
| [183] |
|
| [184] |
|
| [185] |
|
| [186] |
|
| [187] |
|
| [188] |
Struglics, A. et al. The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis. Arthritis. Res. Ther. 18, 223 (2016). |
| [189] |
|
| [190] |
|
| [191] |
|
| [192] |
|
| [193] |
|
| [194] |
|
| [195] |
|
| [196] |
Chamoli, M. et al. A drug-like molecule engages nuclear hormone receptor DAF-12/FXR to regulate mitophagy and extend lifespan. Nat Aging 3, 1529–1543 (2023). |
| [197] |
|
| [198] |
|
| [199] |
|
| [200] |
|
| [201] |
Xu, P. et al. Extracellular vesicles from adipose-derived stem cells ameliorate ultraviolet B-induced skin photoaging by attenuating reactive oxygen species production and inflammation. Stem Cell Res. Ther. 11, 1–14 (2020). |
| [202] |
|
| [203] |
|
| [204] |
|
| [205] |
|
| [206] |
Li, Z. et al. Metformin ameliorates senescence of adipose-derived mesenchymal stem cells and attenuates osteoarthritis progression via the ampk-dependent autophagy pathway. Oxid. Med. Cell Longev. 2022, 4620254 (2022). |
| [207] |
|
| [208] |
|
| [209] |
|
| [210] |
|
| [211] |
Dhanabalan, K. M., Gupta, V. K. & Agarwal, R. Rapamycin–PLGA microparticles prevent senescence, sustain cartilage matrix production under stress and exhibit prolonged retention in mouse joints. Biomater. Sci. 8, 4308–4321 (2020). |
| [212] |
Wan, J. et al. Novel strategy of senescence elimination via toxicity-exempted kinome perturbations by nanoliposome-based thermosensitive hydrogel for osteoarthritis therapy. Adv. Composites Hybrid Mater. 6, 104 (2023). |
| [213] |
|
| [214] |
|
| [215] |
|
| [216] |
Salama, R., Sadaie, M., Hoare, M. & Narita, M. Cellular senescence and its effector programs. Genes Dev. 28, 99–114 (2014). |
| [217] |
|
| [218] |
|
| [219] |
|
| [220] |
|
| [221] |
|
| [222] |
|
| [223] |
|
| [224] |
|
| [225] |
|
| [226] |
Zhang, Y. et al. Gastrodin alleviates rat chondrocyte senescence and mitochondrial dysfunction through Sirt3. Int. Immunopharmacol. 118, 110022 (2023). |
| [227] |
|
| [228] |
|
| [229] |
|
| [230] |
|
| [231] |
|
| [232] |
|
| [233] |
|
| [234] |
|
| [235] |
|
The Author(s)
/
| 〈 |
|
〉 |